Eton Pharmaceuticals, Inc. (ETON) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD (m); Debt, CurrentUSD $8.82M; Long-term Debt, Excluding Current MaturitiesUSD $19.08M; Long-term DebtUSD (m).
- 2026-03-31: Long-term Debt, Current MaturitiesUSD (m); Debt, CurrentUSD $11.81M; Long-term Debt, Excluding Current MaturitiesUSD $18.94M; Long-term DebtUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Debt, CurrentUSD $8.79M; Long-term Debt, Excluding Current MaturitiesUSD $21.77M; Long-term DebtUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $8.79M; Debt, CurrentUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m).
Eton Pharmaceuticals, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Debt, Current USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-term Debt, Gross USD | Debt Instrument, Unamortized Discount USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Debt Instrument, Increase, Accrued Interest USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $8.82M | $19.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $11.81M | $18.94M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $8.79M | $21.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $8.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $2.78M | $27.59M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $2.77M | $27.41M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | $29.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | (m) | $29.81M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | $29.81M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $4.12M | (m) | (m) | (m) | $4.80M | $4.30M | $180.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $4.66M | (m) | (m) | (m) | $5.35M | $4.69M | $32.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $5.02M | (m) | (m) | (m) | $5.91M | $5.08M | $55.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $5.38M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | $5.46M | $80.00K | $6.48M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $1.54M | (m) | (m) | $4.20M | $589.00K | $5.84M | $107.00K | $6.48M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $1.54M | (m) | (m) | $4.55M | $1.18M | $6.23M | $136.00K | $6.47M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $251.00K |
| 2023-03-31 | $1.34M | (m) | (m) | $5.11M | $1.64M | $6.62M | $169.00K | $6.60M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $1.03M | (m) | (m) | $5.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $231.00K |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | $6.62M | $198.00K | $1.85M | $6.59M | (m) | (m) | (m) | (m) |
| 2022-09-30 | $708.00K | (m) | (m) | $5.68M | $186.00K | $6.62M | $229.00K | $1.74M | $6.50M | (m) | (m) | (m) | (m) |
| 2022-06-30 | $364.00K | (m) | (m) | $5.99M | $336.00K | $6.62M | $259.00K | $1.68M | $6.45M | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | $6.33M | $499.00K | $6.62M | $284.00K | $1.68M | $6.45M | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $134.00K |
| 2021-12-31 | $1.42M | (m) | (m) | $5.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | $7.00M | $320.00K | $2.20M | $1.76M | $5.30M | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $107.00K |
| 2021-09-30 | $1.09M | (m) | (m) | $5.55M | $212.00K | $7.00M | $358.00K | $2.20M | $1.76M | $5.30M | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $64.00K |
| 2021-06-30 | $749.00K | (m) | (m) | $5.86M | $384.00K | $7.00M | $395.00K | $2.20M | $1.76M | $5.30M | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $62.00K |
| 2021-03-31 | $385.00K | (m) | (m) | $6.18M | $635.00K | $7.00M | $432.00K | $2.20M | $1.76M | $5.30M | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $48.00K |
| 2020-12-31 | (m) | (m) | (m) | $6.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | $7.00M | $468.00K | $849.00K | $2.20M | $1.76M | $5.30M | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $123.00K |
| 2020-09-30 | (m) | (m) | (m) | $6.50M | $247.00K | $7.00M | $504.00K | $879.00K | $2.20M | $1.76M | $5.30M | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $63.00K |
| 2020-06-30 | (m) | (m) | (m) | $4.59M | $359.00K | $5.00M | $413.00K | $607.00K | $1.36M | $1.33M | $3.99M | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $58.00K |
| 2020-03-31 | (m) | (m) | (m) | $4.57M | $528.00K | $5.00M | $433.00K | (m) | $1.17M | $1.17M | $996.00K | $3.81M | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $82.00K |
| 2019-12-31 | (m) | (m) | (m) | $4.54M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $5.00M | $460.00K | $717.00K | $1.17M | $1.17M | $996.00K | $3.81M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |